Related Experiment Video
Updated: Jul 4, 2026
15:08
Monitoring Astrocyte Reactivity and Proliferation in Vitro Under Ischemic-Like Conditions
Published on: October 21, 2017
GFAPdelta immunostaining improves visualization of normal and pathologic astrocytic heterogeneity
Felipe Andreiuolo1, Marie-Pierre Junier, Elly M Hol
1Department of Pathology, Centre Hospitalier Sainte-Anne, Université Paris Descartes, Paris, France.
Summary
New GFAPdelta markers help distinguish brain glial cells in normal and tumor tissues. This aids neuropathological analysis of gliosis and brain tumors, improving understanding of gliofilament regulation.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Distinguishing glial subpopulations in human brain neuropathology is challenging.
- Lack of specific markers hinders analysis of gliosis and brain tumors.
Purpose of the Study:
- To evaluate GFAPdelta immunostaining as a marker for glial subpopulations.
- To compare GFAPdelta with GFAP and vimentin in normal and pathological brain tissues.
Main Methods:
- Immunostaining for GFAPdelta, GFAP, and vimentin.
- Analysis across a panel of astrogliosis and glioma samples.
- Comparison with normal brain tissue and specific conditions like Chaslin's gliosis.
Main Results:
- GFAPdelta immunostaining identified astrocytes with high GFAP levels, particularly in glia limitans.
- GFAPdelta highlighted reactive astrocytes in Chaslin's gliosis.
- GFAPdelta and vimentin co-localized in normal tissue and gliosis but diverged in gliomas.
Conclusions:
- Combined GFAP, GFAPdelta, and vimentin labeling offers insights into gliofilament regulation.
- GFAPdelta serves as a valuable marker for specific astrocyte populations.
- Improved markers can advance neuropathological studies of brain conditions.
